Isotretinoin Patent Expiration
Isotretinoin was first introduced by Hoffmann La Roche Inc
Isotretinoin Patents
Given below is the list of patents protecting Isotretinoin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Absorica Ld | US9700535 | Oral pharmaceutical composition of isotretinoin | Aug 04, 2035 | Sun Pharm |
| Absorica Ld | US9750711 | Low dose oral pharmaceutical composition of isotretinoin | May 29, 2035 | Sun Pharm |
| Absorica | US7435427 | Pharmaceutical semi-solid composition of isotretinoin |
Sep 21, 2021
(Expired) | Sun Pharm Inds Inc |
| Absorica | US8367102 | Pharmaceutical semi-solid composition of isotretinoin |
Sep 21, 2021
(Expired) | Sun Pharm Inds Inc |
| Absorica | US8952064 | Pharmaceutical semi-solid composition of isotretinoin |
Sep 21, 2021
(Expired) | Sun Pharm Inds Inc |
| Absorica | US9078925 | Pharmaceutical semi-solid composition of isotretinoin |
Sep 21, 2021
(Expired) | Sun Pharm Inds Inc |
| Absorica | US9089534 | Pharmaceutical semi-solid composition of isotretinoin |
Sep 21, 2021
(Expired) | Sun Pharm Inds Inc |
Isotretinoin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List